Biogen soars 13% on report of potential acquisition by South Korea's Samsung GroupBusiness Insider • 12/29/21
Biogen stock surges after report of talks to be bought by Samsung in a deal that could be valued at more than $40 billionMarket Watch • 12/29/21
Biogen Inc. (BIIB) Stock Sinks As Market Gains: What You Should KnowZacks Investment Research • 12/23/21
Japan regulator to continue deliberations on Biogen and Eisai's Alzheimer's drugMarket Watch • 12/22/21
Japan's First Committee on New Drugs of The Pharmaceutical Affairs and Food Sanitation Council Seeks Additional Data; Aducanumab Remains under ReviewGlobeNewsWire • 12/22/21
Biogen's decision to halve price of Alzheimer's drug is ‘a day late and a dollar short,' says Raymond JamesMarket Watch • 12/20/21
Biogen to lower price of Alzheimer's drug aduhlem by 50% starting Jan. 1 to about $28,200 a yearMarket Watch • 12/20/21
Biogen Announces Reduced Price for ADUHELM® to Improve Access for Patients with Early Alzheimer's DiseaseGlobeNewsWire • 12/20/21